The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Artificial intelligence algorithms for recurrence risk score prediction in early-stage breast cancer: A multicenter study of 437 cases.
 
Ertugrul Bayram
No Relationships to Disclose
 
Gul Basaran
No Relationships to Disclose
 
Erhan Gokmen
Stock and Other Ownership Interests - Immunogen; macrogenics
Honoraria - Abdi Ibrahim; Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Celgene; Genekor; Gilead Sciences; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Sandoz-Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Celgene; genekor; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - BMS; MSD Oncology; Novartis; Pfizer; Roche
 
Nil Molinas Mandel
No Relationships to Disclose
 
Basak Oyan
No Relationships to Disclose
 
Necdet Uskent
No Relationships to Disclose
 
Bulent Karagoz
No Relationships to Disclose
 
Yesim Yildirim
No Relationships to Disclose
 
Sinan Karaaslan
No Relationships to Disclose
 
Emine Nilufer Guler
No Relationships to Disclose
 
Yesim Eralp
No Relationships to Disclose
 
ÖZLEM ER
No Relationships to Disclose
 
Aziz Karaoglu
No Relationships to Disclose
 
Seref Komurcu
No Relationships to Disclose
 
Burak Mete
No Relationships to Disclose
 
Fahriye Gemci
No Relationships to Disclose
 
Turgay Ibrikci
No Relationships to Disclose
 
Semra Paydas
No Relationships to Disclose